Bloom Burton lowered shares of CannTrust (NYSE:CTST) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports.
A number of other research analysts have also commented on CTST. Roth Capital started coverage on Electrameccanica Vehicles in a research report on Tuesday, July 9th. They issued a buy rating on the stock. Paradigm Capital reiterated a buy rating on shares of CannTrust in a research report on Thursday, May 23rd. Eight Capital lowered CannTrust from a buy rating to a neutral rating in a research report on Monday, July 8th. BMO Capital Markets upgraded Tourmaline Oil from a market perform rating to an outperform rating in a research report on Thursday, May 30th. Finally, Bank of America reiterated a sell rating on shares of Deutsche Bank in a research report on Monday, July 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of C$7.94.
NYSE CTST opened at C$2.58 on Wednesday. The company has a market cap of $439.20 million, a price-to-earnings ratio of -23.45 and a beta of 3.49. CannTrust has a one year low of C$2.50 and a one year high of C$11.97. The stock’s 50 day simple moving average is C$5.01. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.38 and a current ratio of 5.64.
Institutional investors and hedge funds have recently made changes to their positions in the business. PNC Financial Services Group Inc. bought a new position in shares of CannTrust in the 1st quarter worth $26,000. Shell Asset Management Co. bought a new position in shares of CannTrust in the 1st quarter worth $41,000. Paragon Capital Management LLC bought a new position in shares of CannTrust in the 1st quarter worth $54,000. Winslow Evans & Crocker Inc. bought a new position in shares of CannTrust in the 1st quarter worth $56,000. Finally, K.J. Harrison & Partners Inc bought a new position in shares of CannTrust in the 1st quarter worth $100,000. Hedge funds and other institutional investors own 5.96% of the company’s stock.
CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.
Further Reading: Marijuana Stocks
Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.